alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › markers

markers

12 studies tagged markers, dated 2007-04-10 to 2024-08-22. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Plasma p-tau181 and amyloid markers in Alzheimer's disease: A comparison between Lumipulse and SIMOA 2024-08-22
  2. Dysregulation of Ruminococcaceae and Megamonas could be predictive markers for rapid progression of mild cognitive impairment 2023-08-03
  3. Head-to-head comparison of plasma and PET imaging ATN markers in subjects with cognitive complaints 2023-06-29

Studies

12 studies carry this tag.

Date range

2007 to 2024

Top journals

  • Alzheimer's research & therapy 2
  • Aging cell 1
  • Alzheimer's & dementia : the journal of the Alzheimer's Association 1
  • Journal of Alzheimer's disease : JAD 1
  • Journal of neurology 1

11 journals in all.

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Plasma p-tau181 and amyloid markers in Alzheimer's disease: A comparison between Lumipulse and SIMOA

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Neurobiology of aging 2024-08-22 Biomarkers

    One-hundred-thirthy-three participants, namely 55 A+T+N+ AD, 28 Neurodegenerative disorders (NDD) and 50 controls were enrolled for the study.

  2. Dysregulation of Ruminococcaceae and Megamonas could be predictive markers for rapid progression of mild cognitive impairment

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Microbial pathogenesis 2023-08-03 Biomarkers

    The decrease of Ruminococcaceae and the increase of Megamonas could act as predictive markers for the rapidly progressive MCI.

  3. Head-to-head comparison of plasma and PET imaging ATN markers in subjects with cognitive complaints

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Translational neurodegeneration 2023-06-29 Biomarkers

    Plasma p-tau181, as well as 18 F-florbetapir and 18 F-Florzolotau PET imaging can be considered as interchangeable biomarkers in the assessment of Aβ status in symptomatic stages of AD. 18 F-Florzolotau and 18 F-FDG PET imaging could serve as biomarkers for the severity of cognitive impairment.

  4. A peripheral signature of Alzheimer's disease featuring microbiota-gut-brain axis markers

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Alzheimer's research & therapy 2023-05-31 Biomarkers

    This study tests the hypothesis that GM and mediators of the microbiota-gut-brain axis (MGBA) are associated with the amyloid cascade in sporadic AD.

  5. Sex differences in Alzheimer's disease: plasma MMP-9 and markers of disease severity

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. Alzheimer's research & therapy 2022-11-02 Biomarkers

    MMP-9 may have more detrimental effects on AD-related pathological and cognitive changes in women.

  6. Longitudinal changes in brain oxygen extraction fraction (OEF) in older adults: Relationship to markers of vascular and Alzheimer's pathology

    ✓ Peer-reviewed alzhub usefulness score 59 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2022-07-06 Biomarkers

    Longitudinal OEF change in older adults is primarily related to vascular pathology.

  7. Acute phase markers in CSF reveal inflammatory changes in Alzheimer's disease that intersect with pathology, APOE ε4, sex and age

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Progress in neurobiology 2020-08-31 Biomarkers

    It is unknown how neuroinflammation may feature in the etiology of Alzheimer's disease (AD).

  8. An Update on Blood-Based Markers of Alzheimer's Disease Using the SiMoA Platform

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Neurology and therapy 2019-12-12 Biomarkers

    The development of blood-based biomarkers of Alzheimer's disease (AD) pathology as tools for screening the general population, and as the first step in a multistep process to determine which non-demented individuals are at greatest risk of developing AD dementia, is essential.

  9. Evidence for reduced neurogenesis in the aging human hippocampus despite stable stem cell markers

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Aging cell 2017-08-01 Biomarkers

    Reduced neurogenesis in the aging mammalian hippocampus has been linked to cognitive deficits and increased risk of dementia.

  10. Fingolimod modulates multiple neuroinflammatory markers in a mouse model of Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Scientific reports 2016-04-27 Biomarkers

    Sphingosine 1-phosphate (SP1) receptors may be attractive targets for modulation of inflammatory processes in neurodegenerative diseases.

  11. Homocysteine metabolism and cerebrospinal fluid markers for Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of Alzheimer's disease : JAD 2009-01-01 Biomarkers

    Disturbed homocysteine metabolism is a risk factor for Alzheimer's disease (AD) and may contribute to the disease pathophysiology by increasing both amyloid-beta (Abeta) production and phosphorylated tau (P-tau) accumulation.

  12. CSF neurofilament protein (NFL) -- a marker of active HIV-related neurodegeneration

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Journal of neurology 2007-04-10 Biomarkers

    Cerebrospinal fluid (CSF) NFL concentrations were measured by ELISA (normal < 250 ng/l) in archived samples from 210 HIV-infected patients not taking antiretroviral treatment: 55 with AIDS dementia complex (ADC), 44 with various CNS opportunistic infections/tumours (CNS OIs), 95 without neurological symptoms or signs, and 16 with primary HIV infection (PHI).

All topic tags with their study counts